The Patent Finder

Terms ending in 2040

Intervet Inc.

Every in-force patent on Intervet Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,548,859Method for Producing (5,S)-4-[5-(3,5-Dichlorophenyl)-5-(TRIFLUOROMETHYL)-4HISOXAZOL-3-YL]-2-Methyl-BENZOIC Acid
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 11,858,904Process for Preparing Large Size Isoxazoline Particles
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,239,704Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Multiple Heterologous Antigens
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,697,323Implantable Isoxazoline Pharmaceutical Compositions and Uses Thereof
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,721,839Soft Chewable Veterinary Dosage Form
In force
 · Medium confidence
Intervet Inc.In forceMedium confidence
US 12,721,885A Novel Vaccine Against Heamophilus Parasuis
In force
 · Low confidence
Intervet Inc.In forceLow confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited